Page last updated: 2024-08-21

2-tert-butylhydroquinone and Myocardial Infarction

2-tert-butylhydroquinone has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, P; Liu, N; Peng, QS; Ping, S; Shi, WD; Zhou, NQ	1

Other Studies

1 other study(ies) available for 2-tert-butylhydroquinone and Myocardial Infarction

Article	Year
Tert-butylhydroquinone promotes angiogenesis and improves heart functions in rats after myocardial infarction. Clinical and experimental hypertension (New York, N.Y. : 1993), 2017, Volume: 39, Issue:5 Topics: Androstadienes; Angiogenesis Inducing Agents; Animals; Antioxidants; Cell Movement; Cell Proliferation; Echocardiography; Heart; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Hydroquinones; Hypertension; Male; Myocardial Infarction; Neovascularization, Physiologic; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Wortmannin	2017

Article

Year

Tert-butylhydroquinone promotes angiogenesis and improves heart functions in rats after myocardial infarction.

Clinical and experimental hypertension (New York, N.Y. : 1993), 2017, Volume: 39, Issue:5

Topics: Androstadienes; Angiogenesis Inducing Agents; Animals; Antioxidants; Cell Movement; Cell Proliferation; Echocardiography; Heart; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Hydroquinones; Hypertension; Male; Myocardial Infarction; Neovascularization, Physiologic; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Wortmannin

2017